Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John P Finnigan

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Current Oncology Reports|February 4, 2014
Counseling the patient with potentially HPV-related newly diagnosed head and neck cancerJohn P Finnigan, Andrew G Sikora
Cancer Discovery|July 4, 2019
Immune Checkpoint Blockade Enhances Shared Neoantigen-Induced T-cell Immunity Directed against Mutated Calreticulin in Myeloproliferative NeoplasmsCansu Cimen Bozkus, Vladimir Roudko, John P Finnigan, et al.
Frontiers in Immunology|February 7, 2018
Computational Pipeline for the PGV-001 Neoantigen Vaccine TrialAlex Rubinsteyn, Julia Kodysh, Isaac Hodes, et al.
Nature Communications|March 8, 2024
Structural basis for self-discrimination by neoantigen-specific TCRsJohn P Finnigan, Jenna H Newman, Yury Patskovsky, et al.
Research Square|February 13, 2023
Structural Basis for Self-Discrimination by Neoantigen-Specific TCRsJohn P Finnigan, Jenna H Newman, Yury Patskovsky, et al.
Cancer Research|October 3, 2014
TGFβ receptor 1: an immune susceptibility gene in HPV-associated cancerChaya Levovitz, Dan Chen, Emma Ivansson, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2026
Improving peptide vaccine manufacturability without sacrificing immunogenicity: substitution of methionine and cysteine with oxidation-resistant isosteresAndrew S Ishizuka, Christopher M Garliss, Robert N Goddu, et al.
Nature|June 6, 2020
Author Correction: A conserved dendritic-cell regulatory program limits antitumour immunityBarbara Maier, Andrew M Leader, Steven T Chen, et al.
Nature|April 10, 2020
A conserved dendritic-cell regulatory program limits antitumour immunityBarbara Maier, Andrew M Leader, Steven T Chen, et al.
Nature Immunology|November 3, 2020
Intravenous nanoparticle vaccination generates stem-like TCF1<sup>+</sup> neoantigen-specific CD8<sup>+</sup> T cellsFaezzah Baharom, Ramiro A Ramirez-Valdez, Kennedy K S Tobin, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Current Oncology Reports|February 4, 2014
Counseling the patient with potentially HPV-related newly diagnosed head and neck cancerJohn P Finnigan, Andrew G Sikora
Cancer Discovery|July 4, 2019
Immune Checkpoint Blockade Enhances Shared Neoantigen-Induced T-cell Immunity Directed against Mutated Calreticulin in Myeloproliferative NeoplasmsCansu Cimen Bozkus, Vladimir Roudko, John P Finnigan, et al.
Frontiers in Immunology|February 7, 2018
Computational Pipeline for the PGV-001 Neoantigen Vaccine TrialAlex Rubinsteyn, Julia Kodysh, Isaac Hodes, et al.
Nature Communications|March 8, 2024
Structural basis for self-discrimination by neoantigen-specific TCRsJohn P Finnigan, Jenna H Newman, Yury Patskovsky, et al.
Research Square|February 13, 2023
Structural Basis for Self-Discrimination by Neoantigen-Specific TCRsJohn P Finnigan, Jenna H Newman, Yury Patskovsky, et al.
Cancer Research|October 3, 2014
TGFβ receptor 1: an immune susceptibility gene in HPV-associated cancerChaya Levovitz, Dan Chen, Emma Ivansson, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2026
Improving peptide vaccine manufacturability without sacrificing immunogenicity: substitution of methionine and cysteine with oxidation-resistant isosteresAndrew S Ishizuka, Christopher M Garliss, Robert N Goddu, et al.
Nature|June 6, 2020
Author Correction: A conserved dendritic-cell regulatory program limits antitumour immunityBarbara Maier, Andrew M Leader, Steven T Chen, et al.
Nature|April 10, 2020
A conserved dendritic-cell regulatory program limits antitumour immunityBarbara Maier, Andrew M Leader, Steven T Chen, et al.
Nature Immunology|November 3, 2020
Intravenous nanoparticle vaccination generates stem-like TCF1<sup>+</sup> neoantigen-specific CD8<sup>+</sup> T cellsFaezzah Baharom, Ramiro A Ramirez-Valdez, Kennedy K S Tobin, et al.
Pageof 2